146 related articles for article (PubMed ID: 15999999)
1. Novel alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor antagonists of 2,3-benzodiazepine type: chemical synthesis, in vitro characterization, and in vivo prevention of acute neurodegeneration.
Elger B; Huth A; Neuhaus R; Ottow E; Schneider H; Seilheimer B; Turski L
J Med Chem; 2005 Jul; 48(14):4618-27. PubMed ID: 15999999
[TBL] [Abstract][Full Text] [Related]
2. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
Nielsen EO; Varming T; Mathiesen C; Jensen LH; Moller A; Gouliaev AH; Wätjen F; Drejer J
J Pharmacol Exp Ther; 1999 Jun; 289(3):1492-501. PubMed ID: 10336544
[TBL] [Abstract][Full Text] [Related]
3. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
[TBL] [Abstract][Full Text] [Related]
4. BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.
Weiser T; Brenner M; Palluk R; Bechtel WD; Ceci A; Brambilla A; Ensinger HA; Sagrada A; Wienrich M
J Pharmacol Exp Ther; 1999 Jun; 289(3):1343-9. PubMed ID: 10336525
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, chiral resolution, and enantiopharmacology of a potent 2,3-benzodiazepine derivative as noncompetitive AMPA receptor antagonist.
Zappalà M; Postorino G; Micale N; Caccamese S; Parrinello N; Grazioso G; Roda G; Menniti FS; De Sarro G; Grasso S
J Med Chem; 2006 Jan; 49(2):575-81. PubMed ID: 16420043
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of YM928, a novel moncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist.
Ohno K; Tsutsumi R; Matsumoto N; Yamashita H; Amada Y; Shishikura J; Yatsugi HI; Okada M; Sakamoto S; Yamaguchi T
J Pharmacol Exp Ther; 2003 Jul; 306(1):66-72. PubMed ID: 12660313
[TBL] [Abstract][Full Text] [Related]
7. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
Desai MA; Burnett JP; Ornstein PL; Schoepp DD
J Pharmacol Exp Ther; 1995 Jan; 272(1):38-43. PubMed ID: 7529311
[TBL] [Abstract][Full Text] [Related]
8. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia.
Gill R
Cerebrovasc Brain Metab Rev; 1994; 6(3):225-56. PubMed ID: 7529037
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent.
Micale N; Colleoni S; Postorino G; Pellicanò A; Zappalà M; Lazzaro J; Diana V; Cagnotto A; Mennini T; Grasso S
Bioorg Med Chem; 2008 Mar; 16(5):2200-11. PubMed ID: 18083036
[TBL] [Abstract][Full Text] [Related]
10. Optimized synthesis of AMPA receptor antagonist ZK 187638 and neurobehavioral activity in a mouse model of neuronal ceroid lipofuscinosis.
Elger B; Schneider M; Winter E; Carvelli L; Bonomi M; Fracasso C; Guiso G; Colovic M; Caccia S; Mennini T
ChemMedChem; 2006 Oct; 1(10):1142-8. PubMed ID: 16972289
[TBL] [Abstract][Full Text] [Related]
11. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
[TBL] [Abstract][Full Text] [Related]
12. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
Murray TK; Whalley K; Robinson CS; Ward MA; Hicks CA; Lodge D; Vandergriff JL; Baumbarger P; Siuda E; Gates M; Ogden AM; Skolnick P; Zimmerman DM; Nisenbaum ES; Bleakman D; O'Neill MJ
J Pharmacol Exp Ther; 2003 Aug; 306(2):752-62. PubMed ID: 12730350
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of pharmacological properties of novel annelated 2,3-benzodiazepine derivatives.
Gitto R; Orlando V; Quartarone S; De Sarro G; De Sarro A; Russo E; Ferreri G; Chimirri A
J Med Chem; 2003 Aug; 46(17):3758-61. PubMed ID: 12904081
[TBL] [Abstract][Full Text] [Related]
14. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.
Matucz E; Móricz K; Gigler G; Simó A; Barkóczy J; Lévay G; Hársing LG; Szénási G
Brain Res; 2004 Sep; 1019(1-2):210-6. PubMed ID: 15306255
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
[TBL] [Abstract][Full Text] [Related]
16. Extended therapeutic time window after focal cerebral ischemia by non-competitive inhibition of AMPA receptors.
Elger B; Gieseler M; Schmuecker O; Schumann I; Seltz A; Huth A
Brain Res; 2006 Apr; 1085(1):189-94. PubMed ID: 16580649
[TBL] [Abstract][Full Text] [Related]
17. Novel potent AMPA/kainate receptor antagonists: synthesis and anticonvulsant activity of a series of 2-[(4-alkylsemicarbazono)-(4-amino-phenyl)methyl]-4,5-methylenedioxyphenylacetic acid alkyl esters.
Micale N; Zappalà M; Grasso S; Puja G; De Sarro G; Ferreri G; De Sarro A; Toma L; De Micheli C
J Med Chem; 2002 Sep; 45(20):4433-42. PubMed ID: 12238923
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.
Montero M; Nielsen M; Rønn LC; Møller A; Noraberg J; Zimmer J
Brain Res; 2007 Oct; 1177():124-35. PubMed ID: 17894933
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonist against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures.
May PC; Robison PM; Fuson KS
Neurosci Lett; 1999 Mar; 262(3):219-21. PubMed ID: 10218895
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and AMPA receptor antagonistic activity of a novel 6-nitro-3-oxoquinoxaline-2-carboxylic acid with a substituted phenyl group at the 7 position.
Takano Y; Shiga F; Asano J; Ando N; Uchiki H; Fukuchi K; Anraku T
Bioorg Med Chem; 2005 Oct; 13(20):5841-63. PubMed ID: 15993606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
